Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /The Column Group
The Column Group

The Column Group

DeepTech NativeSan Francisco, United StatesActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

The Column Group is a life sciences VC founded by industry veterans, focused on therapeutics built around differentiated science platforms. The portfolio spans oncology, immunology, and rare disease, with an emphasis on companies with novel mechanisms of action.

The team includes former pharma executives and scientists, and the firm is known for building companies from inception — a company-creat...

Similar Funds

Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Agent Capital

Agent Capital

Waltham, United States

DeepTech NativeBiotechMedTechNeurotechSeedSeries A
ARTIS Ventures

ARTIS Ventures

San Francisco, United States

DeepTech NativeBiotechAI InfrastructureMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Catalio Capital Management

Catalio Capital Management

New York, United States

DeepTech NativeBiotechMedTechSeedSeries A
Clal Biotechnology

Clal Biotechnology

Tel Aviv, Israel

DeepTech NativeBiotechMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.